Clinical Trial Update: Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating indigotindisulfonate sodium as a diagnostic aid to determine ureteral patency in patients with renal impairment, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Injury

Drugs mentioned

• Indigotindisulfonate Sodium (indigotindisulfonate sodium)

Snippet

Sponsor: Prove pharm | Conditions: Ureter Injury | Phase 4 | Status: RECRUITING